Julien Allard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julien Allard has a total of 198 co-authors. Here are the top co-authors by number of shared publications:
- Frédéric Clarençon
Department of Neuroradiology, Pitie-Salpetriere Hospital, Paris, France
8 shared publications - Eimad Shotar
Department of Neuroradiology, Pitie-Salpetriere Hospital, Paris, France
6 shared publications - Kévin Premat
Department of Neuroradiology, Pitie-Salpetriere Hospital, Paris, France
6 shared publications - Gaspard Gerschenfeld
AP-HP, Urgences Cérébro-Vasculaires, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France
5 shared publications - Nader Sourour
Sorbonne University
5 shared publications - Pierre-Marie Chiaroni
Sorbonne University
5 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Springer Nature in Translational Stroke Research
- Vol. 17 (5) , 105
Effect Modification of Rescue Stenting in ICAS-Related Middle Cerebral Artery Occlusion: The Role of Thrombectomy Failure, Stenosis Severity, and ASPECTS
Rescue stenting (RS) is increasingly used for intracranial artery stenosis-related large vessel occlusion (ICAS-LVO), but optimal patient selection remains uncertain. We investigated the baseline and procedural factors associated with receiving RS and whether they modified the association between RS and clinical outcome. This retrospective multicenter study included patients with middle cerebral artery (MCA) ICAS-LVO treated with mechanical thrombectomy (MT) alone or MT followed by RS. Baseline and procedural characteristics associated with receiving RS were identified using multivariable logistic regression and incorporated into inverse probability of treatment weighting models to assess treatment-effect heterogeneity for the 90-day modified Rankin Scale score. Among 264 patients, 193 received RS and 71 MT alone. MT failure, severe stenosis (> 75%), and higher baseline Alberta Stroke Program Early CT Score (ASPECTS) were independently associated with receiving RS. Both MT failure (interaction OR 0.28, 95% CI 0.10–0.83; p for interaction = 0.02) and severe stenosis (interaction OR 0.13, 95% CI 0.03–0.53; p for interaction = 0.004) significantly modified the association between RS and clinical outcome, whereas baseline ASPECTS did not. Within the MT failure subgroup, a significant interaction between severe stenosis and ASPECTS was observed (interaction OR 0.08, 95% CI 0.02–0.38; p for interaction = 0.002), suggesting a more favorable association between RS and outcome at higher ASPECTS values in patients with severe stenosis. In MCA ICAS-LVO, RS may be associated with more favorable outcomes in patients with MT failure, particularly in the presence of severe residual stenosis and preserved ASPECTS. These findings support a more selective approach to RS and warrant prospective validation.
- 23 September 2026
- Published by Springer Nature in Translational Stroke Research
- Vol. 17 (5) , 105
Open AccessEffect Modification of Rescue Stenting in ICAS-Related Middle Cerebral Artery Occlusion: The Role of Thrombectomy Failure, Stenosis Severity, and ASPECTS
Rescue stenting (RS) is increasingly used for intracranial artery stenosis-related large vessel occlusion (ICAS-LVO), but optimal patient selection remains uncertain. We investigated the baseline and procedural factors associated with receiving RS and whether they modified the association between RS and clinical outcome. This retrospective multicenter study included patients with middle cerebral artery (MCA) ICAS-LVO treated with mechanical thrombectomy (MT) alone or MT followed by RS. Baseline and procedural characteristics associated with receiving RS were identified using multivariable logistic regression and incorporated into inverse probability of treatment weighting models to assess treatment-effect heterogeneity for the 90-day modified Rankin Scale score. Among 264 patients, 193 received RS and 71 MT alone. MT failure, severe stenosis (> 75%), and higher baseline Alberta Stroke Program Early CT Score (ASPECTS) were independently associated with receiving RS. Both MT failure (interaction OR 0.28, 95% CI 0.10–0.83; p for interaction = 0.02) and severe stenosis (interaction OR 0.13, 95% CI 0.03–0.53; p for interaction = 0.004) significantly modified the association between RS and clinical outcome, whereas baseline ASPECTS did not. Within the MT failure subgroup, a significant interaction between severe stenosis and ASPECTS was observed (interaction OR 0.08, 95% CI 0.02–0.38; p for interaction = 0.002), suggesting a more favorable association between RS and outcome at higher ASPECTS values in patients with severe stenosis. In MCA ICAS-LVO, RS may be associated with more favorable outcomes in patients with MT failure, particularly in the presence of severe residual stenosis and preserved ASPECTS. These findings support a more selective approach to RS and warrant prospective validation.
- Open Access
- 31 May 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101573
Perioperative management of scheduled interventional neuroradiology procedures: Results of a nationwide French survey
- 31 May 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101573
Open AccessPerioperative management of scheduled interventional neuroradiology procedures: Results of a nationwide French survey
- 24 March 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (6) , e214702
IV Tenecteplase Before Thrombectomy Compared With Thrombectomy Alone in Patients With Stroke Due to a Large Vessel Occlusion
The benefit of IV thrombolysis (IVT) with alteplase before endovascular thrombectomy (EVT) compared with EVT alone has been shown to be limited and time dependent. Data on tenecteplase, its recommended alternative, are limited. We aimed to assess the efficacy and safety of IVT with tenecteplase plus mechanical thrombectomy (TNK + EVT) compared with EVT in patients with large vessel occlusion stroke and determine whether its potential benefit decreases with treatment time. We conducted a retrospective pooled analysis of 2 nationwide, real-world registries of patients with anterior circulation large vessel occlusion stroke within 4.5 hours of known symptom onset and with no contraindication to thrombolysis, treated with TNK + EVT (TETRIS) or EVT (ETIS). The efficacy outcome was the 3-month modified Rankin Scale (mRS) score, analyzed in ordinal and dichotomized (mRS score ≤2) approaches. We used propensity score-weighted logistic regression to assess associations between treatment groups and outcomes of interest. Among 1,890 patients who were analyzed (TNK + EVT: n = 798; EVT: n = 1,092; median age 73 years [interquartile range 61-82]; 49.6% women), the median expected onset-to-thrombolysis time was 146 minutes [interquartile range 119-180]. More than half of patients (n = 1,063; 56.2%) were admitted first to a primary stroke center. All baseline characteristics were balanced between treatment groups after overlap weighting. Overall, TNK + EVT was associated with better 3-month functional outcome over the full mRS (weighted common odds ratio [OR] 1.53 [95% CI 1.29-1.82]; p < 0.001) and regarding functional independence (propensity score overlap weighting [PSOW]-OR 1.50 [95% CI 1.23-1.84]; p < 0.001). This benefit did not differ statistically between patients admitted first to a primary or comprehensive stroke center (p-interaction = 0.12). There was no significant effect of the expected onset-to-thrombolysis time on the association between TNK + EVT and better functional outcome (p-interaction = 0.11). There were no significant differences in parenchymal hematoma (PSOW-OR 1.29 [95% CI 0.94-1.79]; p = 0.12) and symptomatic intracerebral hemorrhage (PSOW-OR 1.13 [95% CI 0.69-1.86]; p = 0.61) rates. Among patients treated within 4.5 hours of symptom onset, TNK + EVT was associated with better functional outcome than EVT, without safety concerns. This benefit does not seem to be time dependent. These findings support the routine use of tenecteplase before EVT in the early time window. This study provides Class II evidence that, in patients with stroke due to anterior circulation large vessel occlusion, IV tenecteplase plus thrombectomy is associated with better functional outcomes at 3 months compared with thrombectomy alone. NCT03776877 (ETIS registry) and NCT05534360 (TETRIS registry).
- 24 March 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (6) , e214702
IV Tenecteplase Before Thrombectomy Compared With Thrombectomy Alone in Patients With Stroke Due to a Large Vessel Occlusion
The benefit of IV thrombolysis (IVT) with alteplase before endovascular thrombectomy (EVT) compared with EVT alone has been shown to be limited and time dependent. Data on tenecteplase, its recommended alternative, are limited. We aimed to assess the efficacy and safety of IVT with tenecteplase plus mechanical thrombectomy (TNK + EVT) compared with EVT in patients with large vessel occlusion stroke and determine whether its potential benefit decreases with treatment time. We conducted a retrospective pooled analysis of 2 nationwide, real-world registries of patients with anterior circulation large vessel occlusion stroke within 4.5 hours of known symptom onset and with no contraindication to thrombolysis, treated with TNK + EVT (TETRIS) or EVT (ETIS). The efficacy outcome was the 3-month modified Rankin Scale (mRS) score, analyzed in ordinal and dichotomized (mRS score ≤2) approaches. We used propensity score-weighted logistic regression to assess associations between treatment groups and outcomes of interest. Among 1,890 patients who were analyzed (TNK + EVT: n = 798; EVT: n = 1,092; median age 73 years [interquartile range 61-82]; 49.6% women), the median expected onset-to-thrombolysis time was 146 minutes [interquartile range 119-180]. More than half of patients (n = 1,063; 56.2%) were admitted first to a primary stroke center. All baseline characteristics were balanced between treatment groups after overlap weighting. Overall, TNK + EVT was associated with better 3-month functional outcome over the full mRS (weighted common odds ratio [OR] 1.53 [95% CI 1.29-1.82]; p < 0.001) and regarding functional independence (propensity score overlap weighting [PSOW]-OR 1.50 [95% CI 1.23-1.84]; p < 0.001). This benefit did not differ statistically between patients admitted first to a primary or comprehensive stroke center (p-interaction = 0.12). There was no significant effect of the expected onset-to-thrombolysis time on the association between TNK + EVT and better functional outcome (p-interaction = 0.11). There were no significant differences in parenchymal hematoma (PSOW-OR 1.29 [95% CI 0.94-1.79]; p = 0.12) and symptomatic intracerebral hemorrhage (PSOW-OR 1.13 [95% CI 0.69-1.86]; p = 0.61) rates. Among patients treated within 4.5 hours of symptom onset, TNK + EVT was associated with better functional outcome than EVT, without safety concerns. This benefit does not seem to be time dependent. These findings support the routine use of tenecteplase before EVT in the early time window. This study provides Class II evidence that, in patients with stroke due to anterior circulation large vessel occlusion, IV tenecteplase plus thrombectomy is associated with better functional outcomes at 3 months compared with thrombectomy alone. NCT03776877 (ETIS registry) and NCT05534360 (TETRIS registry).
- Open Access
- 27 February 2026
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 36 (2) , 1-10
Effect of Stenosis Severity on Outcomes After Rescue Stenting for Acute Middle Cerebral Artery Occlusions: a Real-world Multicenter Analysis
Purpose: Rescue stenting (RS) can achieve durable recanalization in cases of acute large vessel occlusion due to underlying intracranial artery stenosis (ICAS), but its clinical effects may be influenced by procedural factors. This study aimed to evaluate whether the severity of stenosis affects the outcomes after RS. Methods: In this multicenter retrospective study, patients with acute middle cerebral artery occlusion and underlying ICAS were divided into two groups based on the treatment they received: mechanical thrombectomy (MT) + RS ( n = 172) or MT-only ( n = 131). Inverse probability of treatment weighting was used to balance baseline characteristics. We systematically evaluated stenosis thresholds from 40% to 90% to identify the optimal cutoff that best differentiated treatment effects on the 90-day modified Rankin Scale (mRS) score and safety outcomes, including symptomatic intracranial hemorrhage (sICH). Results: A stenosis severity of 75% was identified as the optimal cutoff for effect modification. While RS improved recanalization rates overall, its effect on the 90-day mRS score was beneficial only in patients with > 75% stenosis compared to MT-only (Average Treatment Effect (ATE) −0.98, 95% CI −1.73 to −0.22; p = 0.01). In contrast, it showed a detrimental effect in those with < 75% stenosis (ATE 1.08, 95% CI 0.32 to 1.83; p = 0.005). Furthermore, RS increased the rate of sICH regardless of ICAS severity. Conclusions: The clinical benefit of RS is contingent on the underlying stenosis severity, providing favorable outcomes in patients with high-grade stenoses only. ICAS severity should also be considered for treatment decisions, though these findings require validation in prospective controlled studies.
- 27 February 2026
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 36 (2) , 1-10
Open AccessEffect of Stenosis Severity on Outcomes After Rescue Stenting for Acute Middle Cerebral Artery Occlusions: a Real-world Multicenter Analysis
Purpose: Rescue stenting (RS) can achieve durable recanalization in cases of acute large vessel occlusion due to underlying intracranial artery stenosis (ICAS), but its clinical effects may be influenced by procedural factors. This study aimed to evaluate whether the severity of stenosis affects the outcomes after RS. Methods: In this multicenter retrospective study, patients with acute middle cerebral artery occlusion and underlying ICAS were divided into two groups based on the treatment they received: mechanical thrombectomy (MT) + RS ( n = 172) or MT-only ( n = 131). Inverse probability of treatment weighting was used to balance baseline characteristics. We systematically evaluated stenosis thresholds from 40% to 90% to identify the optimal cutoff that best differentiated treatment effects on the 90-day modified Rankin Scale (mRS) score and safety outcomes, including symptomatic intracranial hemorrhage (sICH). Results: A stenosis severity of 75% was identified as the optimal cutoff for effect modification. While RS improved recanalization rates overall, its effect on the 90-day mRS score was beneficial only in patients with > 75% stenosis compared to MT-only (Average Treatment Effect (ATE) −0.98, 95% CI −1.73 to −0.22; p = 0.01). In contrast, it showed a detrimental effect in those with < 75% stenosis (ATE 1.08, 95% CI 0.32 to 1.83; p = 0.005). Furthermore, RS increased the rate of sICH regardless of ICAS severity. Conclusions: The clinical benefit of RS is contingent on the underlying stenosis severity, providing favorable outcomes in patients with high-grade stenoses only. ICAS severity should also be considered for treatment decisions, though these findings require validation in prospective controlled studies.
- Open Access
- 13 October 2025
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 36 (2) , 1-9
Impact of Stenting with Angioplasty and MTICI 2c-3 Recanalization On Outcome in Acute MCA Occlusion with Underlying Stenosis
Purpose: Mechanical thrombectomy (MT) is standard care for acute large vessel occlusion (LVO), but it fails in 10–20% of cases, often due to underlying intracranial artery stenosis (ICAS). In such cases, rescue stenting (RS), with or without angioplasty, may improve recanalization, but its clinical benefit remains debated. The purpose of this study was to define predictors of clinical outcome in this patient population. Methods: We conducted a retrospective multicenter study including 115 patients with ICAS-related occlusion of the middle cerebral artery (MCA) treated with MT and RS across 27 international stroke centers. Baseline, procedural, and post-procedural variables were analyzed. The outcome measure was the ordinal shift of the 90-day modified Rankin Scale (mRS) score. Stepwise multivariate regression and structural equation modeling (SEM) were used to identify outcome predictors and explore mediation pathways. Results: Successful recanalization (modified Treatment in Cerebral Infarction (mTICI) score ≥ 2b) was achieved in 94.8% of patients, with 73.0% reaching mTICI 2c‑3. SEM showed that baseline Alberta Stroke Program Early CT Score (ASPECTS), stenting with angioplasty and achieving mTICI 2c‑3 were associated with improved functional outcome, mediated by higher post-procedural ASPECTS. Post-procedural ASPECTS influenced functional outcome both directly (estimate = −0.45, p < 0.001) and indirectly by reducing the occurrence of symptomatic intracranial hemorrhage (sICH) (estimate = −0.09, p = 0.004). This model explained 36.5% of the variance in 90-day mRS scores. Conclusion: In patients with acute ICAS-related MCA occlusion, stenting with angioplasty and achieving mTICI 2c–3 recanalization are associated with improved clinical outcome. These benefits are mediated by better post-procedural ASPECTS and reduced sICH. Prospective studies are warranted to confirm these findings.
- 13 October 2025
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 36 (2) , 1-9
Open AccessImpact of Stenting with Angioplasty and MTICI 2c-3 Recanalization On Outcome in Acute MCA Occlusion with Underlying Stenosis
Purpose: Mechanical thrombectomy (MT) is standard care for acute large vessel occlusion (LVO), but it fails in 10–20% of cases, often due to underlying intracranial artery stenosis (ICAS). In such cases, rescue stenting (RS), with or without angioplasty, may improve recanalization, but its clinical benefit remains debated. The purpose of this study was to define predictors of clinical outcome in this patient population. Methods: We conducted a retrospective multicenter study including 115 patients with ICAS-related occlusion of the middle cerebral artery (MCA) treated with MT and RS across 27 international stroke centers. Baseline, procedural, and post-procedural variables were analyzed. The outcome measure was the ordinal shift of the 90-day modified Rankin Scale (mRS) score. Stepwise multivariate regression and structural equation modeling (SEM) were used to identify outcome predictors and explore mediation pathways. Results: Successful recanalization (modified Treatment in Cerebral Infarction (mTICI) score ≥ 2b) was achieved in 94.8% of patients, with 73.0% reaching mTICI 2c‑3. SEM showed that baseline Alberta Stroke Program Early CT Score (ASPECTS), stenting with angioplasty and achieving mTICI 2c‑3 were associated with improved functional outcome, mediated by higher post-procedural ASPECTS. Post-procedural ASPECTS influenced functional outcome both directly (estimate = −0.45, p < 0.001) and indirectly by reducing the occurrence of symptomatic intracranial hemorrhage (sICH) (estimate = −0.09, p = 0.004). This model explained 36.5% of the variance in 90-day mRS scores. Conclusion: In patients with acute ICAS-related MCA occlusion, stenting with angioplasty and achieving mTICI 2c–3 recanalization are associated with improved clinical outcome. These benefits are mediated by better post-procedural ASPECTS and reduced sICH. Prospective studies are warranted to confirm these findings.
- 5 September 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (10) , 2963-2975
Long-term outcome following vertebroplasty or bone cementoplasty in multiple myeloma patients
Objective Evaluating long-term outcomes following cementoplasty in patients with multiple myeloma (MM). Methods This is a single-center, retrospective study on all cementoplasties performed between January 2012 and December 2017. Patients with MM with a control MRI or CT scan beyond 5 years after the procedure were included. Images were reviewed blinded to the patients’ clinical status. Results During the inclusion period, 2085 patients underwent cementoplasty, including 154 patients with MM. Forty-seven patients (33 men (70%); median age 62.2 years [IQR 53.8;69.6]) were included. The patients underwent 74 procedures (142 cemented sites: 129 vertebrae, 11 pelvic girdle cementoplasties, and 2 other sites; 101 (71%) demineralized fractures and 41 (29%) osteolytic lacunae). No serious procedure-related adverse effects were observed. Only 2 (1.4%) recurrent fractures of the cemented bone were observed. At-risk adjacent vertebrae were defined as non-cemented vertebrae, adjacent to a cemented vertebra: 15/109 (14%) fractures of at-risk adjacent vertebrae were documented during follow-up (15/99 [15%] after excluding cervical at-risk vertebrae). Intervertebral disc cement leakage was significantly associated with the occurrence of vertebral fracture at the adjacent level (31% vs. 8.8%, p = 0.022). Fourteen patients (30%) developed a new vertebral fracture that was remote from the cemented site. These were more frequent in patients with higher bone marrow plasmacytosis (median 23% vs. 13%, p = 0.014), relapsed multiple myeloma (86% vs. 55%, p = 0.042) and bone demineralization fractures (93% vs. 48%, p < 0.01). Conclusion Bone cementoplasty for MM is a durable treatment. At-risk adjacent vertebra fracture is a frequent event, prompting a discussion on prophylactic adjacent-level cementoplasty.
- 5 September 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (10) , 2963-2975
Long-term outcome following vertebroplasty or bone cementoplasty in multiple myeloma patients
Objective Evaluating long-term outcomes following cementoplasty in patients with multiple myeloma (MM). Methods This is a single-center, retrospective study on all cementoplasties performed between January 2012 and December 2017. Patients with MM with a control MRI or CT scan beyond 5 years after the procedure were included. Images were reviewed blinded to the patients’ clinical status. Results During the inclusion period, 2085 patients underwent cementoplasty, including 154 patients with MM. Forty-seven patients (33 men (70%); median age 62.2 years [IQR 53.8;69.6]) were included. The patients underwent 74 procedures (142 cemented sites: 129 vertebrae, 11 pelvic girdle cementoplasties, and 2 other sites; 101 (71%) demineralized fractures and 41 (29%) osteolytic lacunae). No serious procedure-related adverse effects were observed. Only 2 (1.4%) recurrent fractures of the cemented bone were observed. At-risk adjacent vertebrae were defined as non-cemented vertebrae, adjacent to a cemented vertebra: 15/109 (14%) fractures of at-risk adjacent vertebrae were documented during follow-up (15/99 [15%] after excluding cervical at-risk vertebrae). Intervertebral disc cement leakage was significantly associated with the occurrence of vertebral fracture at the adjacent level (31% vs. 8.8%, p = 0.022). Fourteen patients (30%) developed a new vertebral fracture that was remote from the cemented site. These were more frequent in patients with higher bone marrow plasmacytosis (median 23% vs. 13%, p = 0.014), relapsed multiple myeloma (86% vs. 55%, p = 0.042) and bone demineralization fractures (93% vs. 48%, p < 0.01). Conclusion Bone cementoplasty for MM is a durable treatment. At-risk adjacent vertebra fracture is a frequent event, prompting a discussion on prophylactic adjacent-level cementoplasty.
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 342-349
Clinical Benefits of 4D-DSA for Analyzing the Angioarchitecture of Brain AVMs Compared with Traditional DSA Techniques: A Systematic and Critical Review of the Literature
Four-dimensional digital subtraction angiography (4D-DSA) has been developed and can be used to evaluate the angioarchitecture of brain arteriovenous malformations (bAVMs). The purpose of this systematic and critical review was to collect and synthesize the available evidence on the clinical benefits of 4D-DSA in evaluating bAVMs angioarchitecture compared with traditional DSA techniques. PubMed, Embase, Cochrane Library, Google Scholar, and International Prospective Register of Ongoing Systematic Reviews (PROSPERO) website. A total of 4264 records were identified through the search process. Following de-duplication and screening based on titles and abstracts, 11 studies underwent full-text review. Ultimately, 7 studies met the eligibility criteria. Information on study designs, technical aspects, and comprehensive evaluation of the angioarchitecture of bAVMs were analyzed. All these studies utilized a commercially available flat panel detector angiography system and post-processing software to generate 4D-DSA, albeit employing different injection protocols. Through a synthesis of qualitative statements and quantitative statistical outcomes, it was found that 4D-DSA demonstrated either equivalent or superior diagnostic performances compared with traditional DSA techniques in assessing the intricate angioarchitecture of bAVMs. Specifically, arterial aneurysms and shunt zones could be better visualized by 4D-DSA because of its adjustable observation angles and time frames. Challenges were noted in analyzing larger and more complex bAVMs, as well as in misinterpretations of venous phases. Most of the included studies were qualitative. According to the analysis by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool, biases could mainly be introduced in the bAVMs selection process and image evaluation. Based on current experience, 4D-DSA has demonstrated notable clinical benefits compared with traditional DSA techniques for analyzing the angioarchitecture of bAVMs. Further investigations should focus on enhancing study design, optimizing image protocols, and increasing 4D-DSA capability, especially for larger bAVMs. 4D-DSA = Four-Dimensional Digital Subtraction Angiography; ARUBA = A Randomized Trial of Unruptured Brain Arteriovenous Malformations; bAVMs = Brain Arteriovenous Malformations; CBCT = Cone Beam Computed Tomography; IQ = Image Quality; MIP = Maximum Intensity Projection; MPR = Multiplanar Reconstruction; PICO = Population, Intervention, Comparison, Outcome; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO = International Prospective Register of Ongoing Systematic Reviews; QUADAS-2 = Quality Assessment of Diagnostic Accuracy Studies-2; VRT = Volume Rendering Technique.
- 11 August 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (2) , 342-349
Clinical Benefits of 4D-DSA for Analyzing the Angioarchitecture of Brain AVMs Compared with Traditional DSA Techniques: A Systematic and Critical Review of the Literature
Four-dimensional digital subtraction angiography (4D-DSA) has been developed and can be used to evaluate the angioarchitecture of brain arteriovenous malformations (bAVMs). The purpose of this systematic and critical review was to collect and synthesize the available evidence on the clinical benefits of 4D-DSA in evaluating bAVMs angioarchitecture compared with traditional DSA techniques. PubMed, Embase, Cochrane Library, Google Scholar, and International Prospective Register of Ongoing Systematic Reviews (PROSPERO) website. A total of 4264 records were identified through the search process. Following de-duplication and screening based on titles and abstracts, 11 studies underwent full-text review. Ultimately, 7 studies met the eligibility criteria. Information on study designs, technical aspects, and comprehensive evaluation of the angioarchitecture of bAVMs were analyzed. All these studies utilized a commercially available flat panel detector angiography system and post-processing software to generate 4D-DSA, albeit employing different injection protocols. Through a synthesis of qualitative statements and quantitative statistical outcomes, it was found that 4D-DSA demonstrated either equivalent or superior diagnostic performances compared with traditional DSA techniques in assessing the intricate angioarchitecture of bAVMs. Specifically, arterial aneurysms and shunt zones could be better visualized by 4D-DSA because of its adjustable observation angles and time frames. Challenges were noted in analyzing larger and more complex bAVMs, as well as in misinterpretations of venous phases. Most of the included studies were qualitative. According to the analysis by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool, biases could mainly be introduced in the bAVMs selection process and image evaluation. Based on current experience, 4D-DSA has demonstrated notable clinical benefits compared with traditional DSA techniques for analyzing the angioarchitecture of bAVMs. Further investigations should focus on enhancing study design, optimizing image protocols, and increasing 4D-DSA capability, especially for larger bAVMs. 4D-DSA = Four-Dimensional Digital Subtraction Angiography; ARUBA = A Randomized Trial of Unruptured Brain Arteriovenous Malformations; bAVMs = Brain Arteriovenous Malformations; CBCT = Cone Beam Computed Tomography; IQ = Image Quality; MIP = Maximum Intensity Projection; MPR = Multiplanar Reconstruction; PICO = Population, Intervention, Comparison, Outcome; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PROSPERO = International Prospective Register of Ongoing Systematic Reviews; QUADAS-2 = Quality Assessment of Diagnostic Accuracy Studies-2; VRT = Volume Rendering Technique.
- Open Access
- 2 April 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (3) , 101338
Imaging follow-up of unruptured intracranial aneurysms treated with flow diverter: Insights from a French collaborative survey
- 2 April 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (3) , 101338
Open AccessImaging follow-up of unruptured intracranial aneurysms treated with flow diverter: Insights from a French collaborative survey
- 26 November 2024
- Published by Springer Nature
- p. 725-733
Mechanical Thrombectomy for Distal Occlusion of the Anterior Cerebral Artery
- 26 November 2024
- Published by Springer Nature
- p. 725-733
Mechanical Thrombectomy for Distal Occlusion of the Anterior Cerebral Artery
- 26 November 2024
- Published by Springer Nature
- p. 705-713
Rescue Stenting After Failed Thrombectomy of a Large Vessel Occlusion Related to Calcified Cerebral Embolus
- 26 November 2024
- Published by Springer Nature
- p. 705-713
Rescue Stenting After Failed Thrombectomy of a Large Vessel Occlusion Related to Calcified Cerebral Embolus